Product Pathways - Apoptosis
FLIP (D16A8) Rabbit mAb #8510
|8510S||100 µl (10 western blots)||---||In Stock||---|
|8510||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
|W||1:1000||Human, Mouse, Rat||Endogenous||55||Rabbit IgG|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation
Specificity / Sensitivity
FLIP (D16A8) Rabbit mAb recognizes endogenous levels of total FLIP protein. This antibody also detects the short isoform of FLIP, FLIPS. The antibody detects a band of unknown origin
at around 70 kDa.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding His160 of human FLIP protein.
Western blot analysis of extracts from various cell lines using FLIP (D16A8) Rabbit mAb.
Cellular FLIP (FLICE inhibitory protein) is a regulator of apoptosis that has various names, such as c-FLIP (1), Casper (2), CLARP (3), FLAME (4), I-FLICE (5), MRIT (6), CASH (7), and Usurpin (8). FLIP is expressed as two alternative splice isoforms, FLIP short (FLIPS) and FLIP long (FLIPL). FLIPS contains two death effector domains (DEDs) like those found on the death receptor adaptor protein FADD and the pro-domain of caspase-8. FLIPL shares significant homology with caspase-8 (FLICE), and contains an additional death effector domain, but FLIPL lacks the catalytic active site of the caspases and does not have protease activity. Both FLIP isoforms have been reported to interact with FADD and pro-caspase-8. The role of FLIP in apoptosis is controversial as some research studies have reported it to be anti-apoptotic, while others claim that it is pro-apoptotic. Overexpression of FLIPL can lead to caspase-8 heterodimers that produce an active protease, resulting in apoptosis. However, at physiological levels, it is thought that the binding of FLIP to the DED of FADD results in inhibition of caspase-8 processing. Reduction of FLIP by siRNA or gene targeting sensitizes cells to death receptor-mediated apoptosis. FLIP has also been implicated in the resistance of cancer cells to apoptosis and is upregulated in some cancer types including Hodgkin's lymphoma and ovarian and colon carcinomas (9).
- Irmler, M. et al. (1997) Nature 388, 190-195.
- Shu, H. B. et al. (1997) Immunity 6, 751-763.
- Inohara, N. et al. (1997) Proc. Natl. Acad. Sci. USA 94, 10717-10722.
- Srinivasula, S. M. et al. (1997) J. Biol. Chem. 272, 18542-18545.
- Hu, S. et al. (1997) J. Biol. Chem. 272, 17255-17257.
- Han, D. K. et al. (1997) Proc. Natl. Acad. Sci. USA 94, 11333-11338.
- Dita, R. M. et al. (1998) Cell Death Differ. 5, 271-288.
- Goltsev, Y. V. et al. (1997) J. Biol. Chem. 272, 19641-19644.
- Kataoka, T. (2005) Crit. Rev. Immunol. 25, 31-58.
- Bucur, O. et al. (2013) Apoptosis 18, 1154-62. Applications: Western Blotting.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.